Investec Bank Plc has filed a Form 8.5 regulatory disclosure relating to share dealings in Advanced Medical Solutions Group Plc on October 7, 2026.
The disclosure was made under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders acting in a client-serving capacity.
Investec Bank Plc is named in the filing as the exempt principal trader, holding recognised intermediary status under the relevant provisions of the Code.
The bank serves as both Advisor and Joint Broker to Advanced Medical Solutions Group Plc, establishing its connected status under the terms of the disclosure.
During the dealing date of October 7, 2026, Investec conducted transactions in ordinary shares of Advanced Medical Solutions Group across both purchase and sale categories.
On the purchase side, Investec acquired 9,580 ordinary shares at a price of 282.25 pence per unit, with both the highest and lowest prices recorded at that same level.
On the sales side, the bank sold a larger position of 18,195 ordinary shares, also transacted at a uniform price of 282.25 pence per unit throughout.
No cash-settled derivative transactions, stock-settled derivative transactions, or options activity was reported as part of this particular filing.
Investec confirmed there are no indemnity arrangements, option agreements, or understandings that could constitute an inducement to deal or refrain from dealing with any party to the offer.
The bank similarly confirmed no agreements or understandings exist relating to voting rights or future acquisition and disposal of securities tied to any derivative instrument.
The disclosure was formally submitted on October 8, 2026, with contact details provided for Abhishek Gawde at Investec in connection with the filing.
Regulatory disclosures of this nature under Rule 8 of the Takeover Code are required to be submitted to a recognised Regulatory Information Service to ensure market transparency.
